Murali Ramaswamy

1.3k total citations
16 papers, 571 citations indexed

About

Murali Ramaswamy is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Murali Ramaswamy has authored 16 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 5 papers in Epidemiology and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Murali Ramaswamy's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Respiratory viral infections research (4 papers) and interferon and immune responses (3 papers). Murali Ramaswamy is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (9 papers), Respiratory viral infections research (4 papers) and interferon and immune responses (3 papers). Murali Ramaswamy collaborates with scholars based in United States, Germany and France. Murali Ramaswamy's co-authors include Dwight C. Look, Sailen Barik, Lei Shi, Mark A. Behlke, Steven M. Varga, Lei Shi, Vira Bitko, Alla Musiyenko, Barsanjit Mazumder and Martha M. Monick and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, Journal of Virology and Journal of Applied Physiology.

In The Last Decade

Murali Ramaswamy

15 papers receiving 565 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Murali Ramaswamy United States 10 347 189 189 179 68 16 571
Cameron Griffiths United States 6 466 1.3× 205 1.1× 76 0.4× 191 1.1× 17 0.3× 17 616
Pablo F. Céspedes Chile 13 349 1.0× 154 0.8× 202 1.1× 222 1.2× 14 0.2× 18 606
M.M. Huckabee United States 7 289 0.8× 159 0.8× 204 1.1× 102 0.6× 13 0.2× 9 519
Kate L. Stokes United States 10 326 0.9× 191 1.0× 177 0.9× 127 0.7× 9 0.1× 13 567
Alwin de Jong Netherlands 11 141 0.4× 36 0.2× 121 0.6× 109 0.6× 28 0.4× 20 383
Wee Peng Poh Australia 7 291 0.8× 176 0.9× 548 2.9× 158 0.9× 13 0.2× 8 848
Regulo Rodriguez Switzerland 10 86 0.2× 79 0.4× 91 0.5× 126 0.7× 46 0.7× 19 403
Elaine M. Castilow United States 8 301 0.9× 165 0.9× 144 0.8× 132 0.7× 6 0.1× 10 475
Vasiliki Triantafyllia Greece 6 203 0.6× 53 0.3× 348 1.8× 359 2.0× 23 0.3× 8 730
Konstantin Doberer Austria 16 159 0.5× 47 0.2× 168 0.9× 101 0.6× 111 1.6× 37 789

Countries citing papers authored by Murali Ramaswamy

Since Specialization
Citations

This map shows the geographic impact of Murali Ramaswamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murali Ramaswamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murali Ramaswamy more than expected).

Fields of papers citing papers by Murali Ramaswamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murali Ramaswamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murali Ramaswamy. The network helps show where Murali Ramaswamy may publish in the future.

Co-authorship network of co-authors of Murali Ramaswamy

This figure shows the co-authorship network connecting the top 25 collaborators of Murali Ramaswamy. A scholar is included among the top collaborators of Murali Ramaswamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murali Ramaswamy. Murali Ramaswamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Lancaster, Lisa, Vincent Cottin, Murali Ramaswamy, et al.. (2024). Bexotegrast in Patients with Idiopathic Pulmonary Fibrosis: The INTEGRIS-IPF Clinical Trial. American Journal of Respiratory and Critical Care Medicine. 210(4). 424–434. 35 indexed citations
2.
Liu, Yi, Peide Li, Murali Ramaswamy, et al.. (2024). Design and baseline characteristics of the ILD-PRO registry in patients with progressive pulmonary fibrosis. BMC Pulmonary Medicine. 24(1). 468–468. 3 indexed citations
3.
Andrade, João A. de, Megan L. Neely, Anne S. Hellkamp, et al.. (2023). Effect of Antifibrotic Therapy on Survival in Patients With Idiopathic Pulmonary Fibrosis. Clinical Therapeutics. 45(4). 306–315. 16 indexed citations
4.
Case, Amy Hajari, Scott Beegle, David Hotchkin, et al.. (2023). Defining the pathway to timely diagnosis and treatment of interstitial lung disease: a US Delphi survey. BMJ Open Respiratory Research. 10(1). e001594–e001594. 4 indexed citations
5.
Cottin, Vincent, Murali Ramaswamy, Jonathan Goldin, et al.. (2023). PLN-74809 Shows Favorable Safety and Tolerability and Indicates Antifibrotic Activity in a Phase 2a Study for the Treatment of Idiopathic Pulmonary Fibrosis. A2777–A2777. 2 indexed citations
6.
Lobo, Leonard J., Yi Liu, Peide Li, et al.. (2023). Characteristics of patients with progressive fibrosing ILDs in the ILD-PRO Registry. PA2882–PA2882. 1 indexed citations
7.
Andrade, João A. de, Megan L. Neely, Anne S. Hellkamp, et al.. (2022). Effect of Antifibrotic Therapy on Survival in Patients with Idiopathic Pulmonary Fibrosis: Data from the IPF-PRO Registry. A2427–A2427.
8.
Neely, Megan L., Anne S. Hellkamp, Daniel A. Culver, et al.. (2022). Effect of Antifibrotic Therapy on Survival in Patients with Idiopathic Pulmonary Fibrosis. SSRN Electronic Journal. 2 indexed citations
10.
Prasse, Antje, Murali Ramaswamy, Lin Pan, et al.. (2019). A Phase 1b Study of Vismodegib with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis. Pulmonary Therapy. 5(2). 151–163. 14 indexed citations
11.
Ramaswamy, Murali, Dayna J. Groskreutz, & Dwight C. Look. (2009). Recognizing the Importance of Respiratory Syncytial Virus in Chronic Obstructive Pulmonary Disease. COPD Journal of Chronic Obstructive Pulmonary Disease. 6(1). 64–75. 29 indexed citations
12.
Shi, Lei, Murali Ramaswamy, Lori Manzel, & Dwight C. Look. (2007). Inhibition of Jak1-Dependent Signal Transduction in Airway Epithelial Cells Infected with Adenovirus. American Journal of Respiratory Cell and Molecular Biology. 37(6). 720–728. 17 indexed citations
13.
Nishiyama, Steven K., et al.. (2007). Limb-specific differences in flow-mediated dilation: the role of shear rate. Journal of Applied Physiology. 103(3). 843–851. 52 indexed citations
14.
Bitko, Vira, Barsanjit Mazumder, Alla Musiyenko, et al.. (2006). Nonstructural Proteins of Respiratory Syncytial Virus Suppress Premature Apoptosis by an NF-κB-Dependent, Interferon-Independent Mechanism and Facilitate Virus Growth. Journal of Virology. 81(4). 1786–1795. 134 indexed citations
15.
Ramaswamy, Murali, Lei Shi, Steven M. Varga, et al.. (2005). Respiratory syncytial virus nonstructural protein 2 specifically inhibits type I interferon signal transduction. Virology. 344(2). 328–339. 138 indexed citations
16.
Ramaswamy, Murali, Lei Shi, Martha M. Monick, Gary W. Hunninghake, & Dwight C. Look. (2004). Specific Inhibition of Type I Interferon Signal Transduction by Respiratory Syncytial Virus. American Journal of Respiratory Cell and Molecular Biology. 30(6). 893–900. 94 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026